This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Rosenberg, K. D. Articles by Sandoval, A. P. Search for Related Content PubMed PubMed Citation Articles by Rosenberg, K. D. Articles by Sandoval, A. P. Related Collections Miscellaneous Social Bookmarking                         What's this?

PEDIATRICS Vol. 111 No. 5 May 2003, pp. 1142-1145

Pregnancy Intendedness and the Use of Periconceptional Folic Acid

Kenneth D. Rosenberg, MD, MPH^*,, Jill M. Gelow and Alfredo P. Sandoval, MBA, MS^*

^* Office of Family Health, Oregon Department of Human Services, Portland, Oregon
Department of Public Health and Preventive Medicine, Oregon Health & Sciences University, Portland, Oregon

--> Objective. Periconceptional use of folic acid can prevent birth defects, including at least 50% of neural tube defects. This study used an ongoing surveillance system to explore the association between pregnancy intendedness and women taking periconceptional folic acid.

Methods. Oregon Pregnancy Risk Assessment Monitoring System (PRAMS) surveys a stratified random sample of women after a live birth. In 1998–1999, 1867 women completed the survey (64.0% response rate); responses were weighted for nonresponse. Women were asked whether they took folic acid most days in the month before becoming pregnant.

Results. Overall, 33.2% of women took folic acid most days in the month before becoming pregnant, and 39.9% said that their pregnancy was unintended. Adolescent mothers were less likely to take periconceptional folic acid (9.2%) and more likely to report unintended pregnancy (62.0%) than older women. Overall, women who said that their pregnancy was intended were more likely to report that they had taken periconceptional folic acid (odds ratio: 4.75; 95% confidence interval: 3.16–7.14); after controlling for maternal age and income the odds ratio was 3.70 (95% confidence interval: 2.38–5.56).

Conclusions. Women whose pregnancies were intended were more likely to have been taking periconceptional folic acid than women whose pregnancies were unintended. The importance of fertile women’s taking daily multivitamins that contain 400 µg (0.4 mg) of folic acid should be stressed among women who are not contemplating pregnancy, especially adolescents and low-income women.

Key Words: folic acid • pregnancy • birth defect

Abbreviations: NTD, neural tube defect • PRAMS, Pregnancy Risk Assessment Monitoring System

---

Received for publication Oct 2, 2002; Accepted Dec 4, 2002.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. Hasan, A. F. Olshan, A. H. Herring, D. A. Savitz, A. M. Siega-Riz, and K. E. Hartmann Self-reported Vitamin Supplementation in Early Pregnancy and Risk of Miscarriage Am. J. Epidemiol., June 1, 2009; 169(11): 1312 - 1318. [Abstract] [Full Text] [PDF]

				Q.-H. Yang, H. K Carter, J. Mulinare, R. Berry, J. Friedman, and J D. Erickson Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001-2002 Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1409 - 1416. [Abstract] [Full Text] [PDF]

				S. D. Grosse, N. J. Waitzman, P. S. Romano, and J. Mulinare Reevaluating the Benefits of Folic Acid Fortification in the United States: Economic Analysis, Regulation, and Public Health Am J Public Health, November 1, 2005; 95(11): 1917 - 1922. [Abstract] [Full Text] [PDF]